{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:28:35Z","timestamp":1791109715100,"version":"4.1.0"},"reference-count":110,"publisher":"Informa UK Limited","issue":"7","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.2217\/pgs.10.77","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T10:04:32Z","timestamp":1278410672000},"page":"973-987","source":"Crossref","is-referenced-by-count":93,"title":["Pharmacogenetics of Drug Hypersensitivity"],"prefix":"10.1080","volume":"11","author":[{"given":"Elizabeth J","family":"Phillips","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology & Immunogenetics, Royal Perth Hospital, Perth, Australia"},{"name":"Departments of Clinical Immunology & Infectious Diseases, Sir Charles Gairdner Hospital, Perth, Australia"},{"name":"Centre for Clinical Pharmacology & Infectious Diseases, Perth, Australia"},{"name":"Institute for Immunology & Infectious Diseases, Murdoch University\rPerth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A","family":"Mallal","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology & Immunogenetics, Royal Perth Hospital, Perth, Australia"},{"name":"Departments of Clinical Immunology & Infectious Diseases, Sir Charles Gairdner Hospital, Perth, Australia"},{"name":"Centre for Clinical Pharmacology & Infectious Diseases, Perth, Australia"},{"name":"Institute for Immunology & Infectious Diseases, Murdoch University\rPerth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,7,6]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.all.0000173785.81024.33"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328330a3b8"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/428486a"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01022.x"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01719.x"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f3ef9c"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660330082014"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07873-X"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08158-8"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200501030-00014"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000238408.82947.09"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32801199d9"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32831d0faf"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000199500.46842.4a"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.7.6.813"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.7.890"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62997-3"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f37812"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.5.717"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70404-X"},{"key":"e_1_3_2_3_23_1","first-page":"345","article-title":"Susceptibility to drug induced liver injury determined by HLA Class II genotype. Presented at: 59th Annual Meeting of the American Association for the Study of Liver Diseases. CA, USA.","volume":"48","author":"Donaldson PT","year":"2008","unstructured":"Donaldson PT , BhatnagarP, GrahamJ et al. Susceptibility to drug induced liver injury determined by HLA Class II genotype. Presented at: 59th Annual Meeting of the American Association for the Study of Liver Diseases. CA, USA. Hepatology 48(Suppl.) , 345 (2008).","journal-title":"Hepatology"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1240009"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.379"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500458"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80347-7"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70007-9"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117854"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810220061007"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90109-M"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91554-8"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0895-5"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.02197.x"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.1.85"},{"key":"e_1_3_2_3_36_1","first-page":"41","article-title":"Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.","volume":"21","author":"Rodriguez-Perez M","year":"1994","unstructured":"Rodriguez-Perez M , Gonzalez-DominguezJ, MataranL et al. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate. J. Rheumatol. 21 , 41\u201343 (1994).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1985.tb00932.x"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70243-5"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6362.338"},{"key":"e_1_3_2_3_40_1","first-page":"35","article-title":"HLA-A-B- and -DR antigens in relation to gold and d-penicillamine toxicity in Greek patients with RA.","volume":"4","author":"Pachoula-Papasteriades C","year":"1986","unstructured":"Pachoula-Papasteriades C , BokiK, Varla-LeftherioticM et al.: HLA-A-B- and -DR antigens in relation to gold and d-penicillamine toxicity in Greek patients with RA.Dis. Markers4 , 35\u201341 (1986).","journal-title":"Dis. Markers"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2009.04.007"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.1"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.145.1.67"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08167.x"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2005.tb00885.x"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07332.x"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.8"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.02.029"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071059"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(00)00397-8"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.17"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890460044005"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1993.01680220104023"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199308010-00008"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1086\/342571"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03508.x"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1884"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09357.x"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64284-8"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01622.x"},{"key":"e_1_3_2_3_62_1","first-page":"231","article-title":"HLA and drug-induced toxicity:","volume":"11","author":"Phillips E","year":"2009","unstructured":"Phillips E , MallalS: HLA and drug-induced toxicity:Curr. Opin. Mol. Ther.11 , 231\u2013242 (2009).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.09.006"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80132-6"},{"key":"e_1_3_2_3_65_1","first-page":"222","article-title":"A near fatal hypersensitivity reaction to abacavir: case report and literature review.","volume":"11","author":"Shapiro M","year":"2001","unstructured":"Shapiro M , WardKM, SternJJ: A near fatal hypersensitivity reaction to abacavir: case report and literature review.AIDS Read.11 , 222\u2013226 (2001).","journal-title":"AIDS Read."},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)85132-3"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A022"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1517\/phgs.5.2.203.27481"},{"key":"e_1_3_2_3_69_1","first-page":"L88","article-title":"Diagnosis of abacavir hypersensitivity reactions among patients not receiving abacavir in two blinded studies.","volume":"8","author":"Hernandez J","year":"2003","unstructured":"Hernandez J , CutrellA, BennyT et al.: Diagnosis of abacavir hypersensitivity reactions among patients not receiving abacavir in two blinded studies.Antivir. Ther.8 , L88 (2003).","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1086\/424009"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.7.769"},{"key":"e_1_3_2_3_72_1","first-page":"6","volume":"13","year":"2008","unstructured":"Dart Trial Team: Twenty-four week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine\/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA) Trop. Med. Int. Health13 , 6\u201316 (2008).","journal-title":"Trop. Med. Int. Health"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211080-00017"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000171414.99409.fb"},{"key":"e_1_3_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f7cb60"},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706135"},{"key":"e_1_3_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1086\/529382"},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1086\/504874"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318046ea31"},{"key":"e_1_3_2_3_80_1","first-page":"14","volume":"11","author":"Reeves I","year":"2006","unstructured":"Reeves I , ChurchillD, FisherM. Screening for HLA-B*5701 reduces the frequencies of abacavir hypersensitivity reactions. Antiviral Ther.11(Suppl. 3) , 14 (2006).","journal-title":"Antiviral Ther."},{"key":"e_1_3_2_3_81_1","unstructured":"Trottier B ThomasR NguyenVK MachoufN: How effectively HLA screening can reduce the early discontinuation of abacavir in real life. Presented at: International AIDS Society Meeting. Sydney Australia July 22\u201325 (2007) (Abstract MOPEB002)."},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2009.01383.x"},{"key":"e_1_3_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328273bc07"},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32830719aa"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.04.020"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350801300202"},{"key":"e_1_3_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3280119579"},{"key":"e_1_3_2_3_88_1","first-page":"247","article-title":"Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals.","volume":"18","author":"Phillips E","year":"2008","unstructured":"Phillips E , NolanD, ThorbornD et al.: Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals.Eur. J. Dermatol.18 , 247 (2008).","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32825ea68a"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"crossref","unstructured":"Shenton JM PopovicM UetrechtJP: Nevirapine hypersensitivity. In: Drug Hypersensitivity . Pichler WJ (Ed.) Karger AG Basel Switzerland 115\u2013128 (2007).","DOI":"10.1159\/000104195"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-6-22"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000171419.29905.93"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921060-00005"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-004-1736-z"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000189800.88596.7a"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)02008-X"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.9.11.1617"},{"key":"e_1_3_2_3_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02269.x"},{"key":"e_1_3_2_3_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500356"},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1086\/605292"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.5.555"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256308"},{"key":"e_1_3_2_3_103_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350701200708"},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2005.00401.x"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00840.x"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000197468.16126.cd"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1086\/591184"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2009.58"},{"key":"e_1_3_2_3_109_1","doi-asserted-by":"crossref","unstructured":"Phillips EJ MallalSA: Chapter 20: HLA and drug reactions. In: The HLA Complex in Biology and Medicine a Resource Book . Narinder K Mehra (Ed.). Jaypee Brothers New Delhi India (2010).","DOI":"10.5005\/jp\/books\/11170_20"},{"key":"e_1_3_2_4_2_1","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services. 1 December 2009 1\u2013161 www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf (Accessed 21December2009)"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.10.77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:34:50Z","timestamp":1715956490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.10.77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":110,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.2217\/pgs.10.77"],"URL":"https:\/\/doi.org\/10.2217\/pgs.10.77","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}